0001209191-18-047853.txt : 20180821
0001209191-18-047853.hdr.sgml : 20180821
20180821192935
ACCESSION NUMBER: 0001209191-18-047853
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180821
FILED AS OF DATE: 20180821
DATE AS OF CHANGE: 20180821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cao Han PHD
CENTRAL INDEX KEY: 0001745596
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38613
FILM NUMBER: 181031212
MAIL ADDRESS:
STREET 1: C/O BIONANO GENOMICS, INC.
STREET 2: 9640 TOWNE CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioNano Genomics, Inc
CENTRAL INDEX KEY: 0001411690
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 9640 TOWNE CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 888-7600
MAIL ADDRESS:
STREET 1: 9640 TOWNE CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: BioNanomatrix Inc
DATE OF NAME CHANGE: 20070906
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-08-21
0
0001411690
BioNano Genomics, Inc
BNGO
0001745596
Cao Han PHD
C/O BIONANO GENOMICS, INC.
9640 TOWNE CENTRE DR #100
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
1413
D
Stock Option (right to buy)
291.04
2019-01-14
Common Stock
46
D
Stock Option (right to buy)
38.52
2020-04-01
Common Stock
46
D
Stock Option (right to buy)
42.80
2021-08-09
Common Stock
2344
D
Stock Option (right to buy)
64.20
2025-01-28
Common Stock
1599
D
Stock Option (right to buy)
64.20
2025-01-28
Common Stock
2557
D
Stock Option (right to buy)
1.28
2027-02-06
Common Stock
51329
D
Series B Convertible Preferred Stock
0.00
Common Stock
254275
D
Series C Convertible Preferred Stock
0.00
Common Stock
52720
D
Series D Convertible Preferred Stock
0.00
Common Stock
4362062
D
Series D-1 Convertible Preferred Stock
0.00
Common Stock
104167
D
Series D Convertible Preferred Stock Warrant (Right to Buy)
0.41
2016-04-04
2026-03-04
Series D Convertible Preferred Stock
10731083
D
The shares subject to the option are fully vested and exercisable.
25% of the shares vested on January 29, 2016, and the remaining shares vest in 12 equal quarterly installments thereafter.
25% of the shares vested on February 7, 2017, and the remaining shares vest in 12 equal quarterly installments thereafter.
The convertible preferred stock is convertible at any time at the holder's election and automatically converts upon the consummation of a qualified public offering of the registrant. There is no expiration date for any series of preferred stock.
/s/ Han Cao, Ph.D.
2018-08-21